STOCK PLUMMETS AFTER NOVO NORDISK DEAL FAILURE

Shares of HIMS experienced a dramatic slump today following the unexpected termination of its deal with pharmaceutical giant Novo Nordisk. Investors responded negatively to here the news, sending the company's stock price plummeting by over 20%. The reason for the dissolution of the partnership remains unclear, but industry analysts speculate that